Community and Continuing Medical Education

Target Audience: UConn Health faculty, residents, medical students, and other mental health professionals
Learning Objectives: Participants (will be able to):
1. Describe types of cognition oriented treatments as well as cognitive and neurophysiological evidence supporting/refuting their use
2. Describe potential uses of transcranial direct current stimulation (tDCS) for cognitive deficits in older adults
3. Identify remaining knowledge gaps for cognition oriented treatments and tDCS
~ There is no CME credit associated with this session ~

About the Speaker: Dr. Benjamin Hampstead is the Director of the Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI) at the University of Michigan School of Medicine. Dr. Hampstead is a board-certified Clinical Neuropsychologist who earned his PhD in Clinical Psychology (Neuropsychology emphasis) from Drexel University. He is the Stanley Berent, Ph.D., Collegiate Professor of Psychology in the Department of Psychiatry at the University of Michigan, Staff Neuropsychologist in the VA Ann Arbor Healthcare System, and Clinical Core Leader of the NIA funded Michigan Alzheimer’s Disease Research Center. Dr. Hampstead’s research focuses on non-pharmacologic approaches to maximize cognitive functioning in older adults across the dementia spectrum. Specifically, he uses cognition-oriented treatments and non-invasive brain stimulation to enhance cognition, typically within the context of a randomized controlled trial format. Dr. Hampstead integrates these techniques with functional and structural neuroimaging in order to predict treatment response, identify the neuroplastic changes following treatment, and plan/develop new interventions. Ongoing work integrates amyloid and tau positron emission tomography (PET) in order to better characterize participant characteristics associated with treatment response. He has maintained continuous federal funding for his work since earning his doctorate (15+ years), with most support from the Department of Veterans Affairs and National Institute on Aging.

“Investigating Selective Advantage of Mismatch Repair Loss in Colonic Organoids”

Dr. Stephen C. Blacklow, Gustavus Adolphus Pfeiffer Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Title: “A Journey from Membrane to Nucleus: Notch Signaling from the Outside-In”

Host: Dr. Wolfgang Peti

“From bench to store shelf: the science behind OTC skincare and why you should care”

Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and the Department of Dermatology

Speaker: Kavita Mariwalla, MD - Director, Mariwalla Dermatology, West Islip, NY
Date: Wednesday, May 1, 2024
Time: 8am – 9am lecture – Open to All, 9am – 12pm Virtual Patient Viewing and Discussion – Open ONLY to Medical Providers
Location: Dermatology Waiting Room, 21 South Road, 2nd Floor, Farmington, CT for in-person and Zoom option as well:
https://us06web.zoom.us/j/3422377000?pwd=NWNMQTJ3QW5BVUtROU9YdnBKVGp3UT09
Meeting ID: 342 237 7000 Passcode: uconnderm
Target Audience: UCHC dermatologists and dermatology residents. All other podiatrists, nurses, nurse practitioners, residents, students, and greater Hartford dermatologists are encouraged to attend.

Learning Objectives: Participants will (be able to):

a. Recite the evidence or expert opinion associated with understanding the scientific basis behind cleansers and moisturizers.
b. Identify one or more barriers to implementing the evidence or expert opinion in practice. Recommend OTC products to enhance prescriptions for the treatment and management of acne and rosacea.
c. Describe one or more strategies necessary either to implement the evidence/expert opinion or overcome any barrier to implementation. Integrate cosmeceuticals into dermatologic practice and select specific products for distinct patient needs.

Speaker Disclosure Statement:

Dr. Mariwalla in her role as [speaker] for this educational event, has a relevant financial relationship(s) with Abbvie, Merz, Revance, Belle. AI, L’Oreal group of companies, SkinFix, Neutrogena & Boards University that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. The following safeguards have been put in place to avoid the insertion of commercial bias into the content: The activity director determined that the financial relationship of the speaker is outside the area of the content of the program.

Dr. Mariwalla will not be discussing the off-labeled, or investigational use of any product or device.

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Activity Director Disclosure Statement:
Dr. Michael Storonsky, as the activity director, for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed.

Planning Committee Disclosure Statement:
Dr. Philip Kerr and Christina Iwanik as member(s) of the planning committee, for this educational event, has/have no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed.

Commercial Support Statement:
This CME activity has no commercial support associated with it.

Evaluations: Participants are required to complete an electronic evaluation in order to obtain CME Credits. An email from MyEvaluations.com with instructions will be sent to participants. Please complete the evaluation within one week of receiving the email. If you do not receive an evaluation assignment from MyEvaluations.com within 10 business days of this activity, please contact the Department that hosted this activity (indicated above) to ensure that your MyEvaluations.com account is set up and your participation in this activity was forwarded to the CME office.